K. Stewart

发表

Echinocandins in the treatment of candidaemia and invasive candidiasis: clinical and economic perspectives.

C. Neoh, D. Kong, M. Slavin, 2014, International journal of antimicrobial agents.

Cost-effectiveness evaluation of voriconazole versus liposomal amphotericin B as empirical therapy for febrile neutropenia in Australia.

D. Liew, D. Al-Badriyeh, D. Kong, 2008, The Journal of antimicrobial chemotherapy.

Economic evaluation of micafungin versus caspofungin for the treatment of candidaemia and invasive candidiasis

D. Liew, C. Neoh, M. Slavin, 2013, Internal medicine journal.

Economic evaluation of micafungin vs. Liposomal Amphotericin B (LAmB) for the treatment of candidaemia and Invasive Candidiasis (IC)

D. Liew, D. Kong, C. Neoh, 2013, Mycoses.

Cost-effectiveness analysis of anidulafungin versus fluconazole for the treatment of invasive candidiasis.

D. Liew, C. Neoh, D. Kong, 2011, The Journal of antimicrobial chemotherapy.

Antifungal Prophylaxis in Lung Transplantation—A World‐wide Survey

G. Snell, T. Kotsimbos, C. Neoh, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Antifungal prophylaxis in lung transplantation.

G. Snell, C. Neoh, D. Kong, 2014, International journal of antimicrobial agents.

Successful Use of Topical Voriconazole 1% Alone as First-Line Antifungal Therapy Against Candida albicans Keratitis

D. Al-Badriyeh, D. Kong, K. Stewart, 2009, The Annals of pharmacotherapy.

Stability of extemporaneously prepared voriconazole ophthalmic solution.

J. Li, D. Al-Badriyeh, D. Kong, 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Successful Salvage Treatment of Scedosporium apiospermum Keratitis with Topical Voriconazole After Failure of Natamycin

D. Al-Badriyeh, D. Kong, K. Stewart, 2009, The Annals of pharmacotherapy.

Prospective Open-Label Study of the Administration of Two-Percent Voriconazole Eye Drops

D. Al-Badriyeh, M. Daniell, D. Kong, 2009, Antimicrobial Agents and Chemotherapy.

Pharmacoeconomics of voriconazole in the management of invasive fungal infections

D. Al-Badriyeh, C. Neoh, D. Kong, 2010, Expert review of pharmacoeconomics & outcomes research.

Open-Label Study of Absorption and Clearance of 1% Voriconazole Eye Drops

D. Al-Badriyeh, V. Jhanji, R. Vajpayee, 2016, Antimicrobial Agents and Chemotherapy.

Stability of Extemporaneously Prepared 0.5-Percent Caspofungin Eye Drops: a Potential Cost-Savings Exercise

D. Kong, J. Jacob, C. Neoh, 2012, Antimicrobial Agents and Chemotherapy.

Clinical utility of caspofungin eye drops in fungal keratitis.

M. Daniell, C. Neoh, D. Kong, 2014, International journal of antimicrobial agents.

Treatment of Alternaria Keratitis with Intrastromal and Topical Caspofungin in Combination with Intrastromal, Topical, and Oral Voriconazole

R. Vajpayee, D. Kong, C. Neoh, 2011, The Annals of pharmacotherapy.

Penetration of Topically Administered 0.5-Percent Caspofungin Eye Drops into Human Aqueous Humor

R. Vajpayee, D. Kong, C. Neoh, 2011, Antimicrobial Agents and Chemotherapy.

Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis

D. Al-Badriyeh, D. Kong, C. Neoh, 2010, Clinical ophthalmology.

Squamous cell carcinoma of the skin and voriconazole therapy in lung transplant recipients: a case series

G. Snell, C. Neoh, D. Kong, 2017 .

Rapid and Sensitive Liquid Chromatography/Mass Spectrometry Assay for Caspofungin in Human Aqueous Humor

J. Li, R. Vajpayee, D. Kong, 2010, Antimicrobial Agents and Chemotherapy.

Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia.

D. Liew, D. Al-Badriyeh, K. Thursky, 2010, The Journal of antimicrobial chemotherapy.

Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia

D. Liew, D. Al-Badriyeh, D. C. Kong, 2012, Mycoses.

Economic impact of caspofungin as compared with liposomal amphotericin B for empirical therapy in febrile neutropenia in Australia.

D. Liew, D. Al-Badriyeh, D. Kong, 2009, The Journal of antimicrobial chemotherapy.

Lung transplant recipients receiving voriconazole and skin squamous cell carcinoma risk in Australia

G. Snell, T. Kotsimbos, C. Neoh, 2014, The Medical journal of Australia.

Preemptive treatment with voriconazole in lung transplant recipients

G. Snell, T. Kotsimbos, C. Neoh, 2013, Transplant infectious disease : an official journal of the Transplantation Society.